In episode 448 of #CutTheClutter, Shekhar Gupta delves into how coronavirus has affected the Indian subcontinent differently, new findings on HCQ and Remdesivir trials.
In episode 445 of #CutTheClutter, Shekhar Gupta draws from an interview with Dr Raman R. Gangakhedkar, head of epidemiology at ICMR, and examines various issues related to Covid-19.
Modi is a prime minister who never reverses his domestic decisions. But after two phone calls, India partially lifted its ban on hydroxychloroquine export to supply to the US.
Amid incidents of hoarding and self-prescription of these potential drugs for Covid-19, health ministry says awareness must be spread about their ‘rational’ use.
Speaking exclusively to ThePrint, German Ambassador to India Walter J. Lindner says the carmakers are engaged in community work in India to help people fight Covid-19.
HCQ didn’t help patients clear virus better than standard care & was much more likely to cause side effects, according to study of 150 patients in China.
The anti-malarial drug has been identified by the USFDA as a possible treatment for Covid-19 and it is being tested on more than 1,500 coronavirus patients in New York.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.
Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.
COMMENTS